Overview
Randall Hughes is a Hematologist and an Oncologist in Dallas, Texas. Dr. Hughes is rated as an Experienced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Endoscopy.
His clinical research consists of co-authoring 27 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5323 Harry Hines Blvd, Dallas, TX 75390
Additional Areas of Focus
Dr. Hughes has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Texas Southwestern Medical Center At Dallas
Sanjay Chandrasekaran is a Hematologist and an Oncologist in Dallas, Texas. Dr. Chandrasekaran is rated as an Advanced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Bone Tumor, Liposarcoma, Epithelioid Sarcoma, and Myxoid Liposarcoma.
Texas Oncology, P.A.
Dr. Nadler specializes in medical oncology. He serves as a Medical Director of US Oncology Health Informatics and Internet Technology. He remains active in USON research committees in lung cancer, head and neck cancer, and sarcoma within the developmental committees. Dr. Nadler received a BA with highest honors from Wesleyan University double majoring in molecular biology and philosophy. He received his joint MD/MPP from Harvard Medical School and a Master in Public Policy from Harvard University's Kennedy School of Government. Dr. Nadler then completed his internship and residency in Boston, MA, at Brigham and Women's Hospital in Boston and his oncology fellowship at Dana Farber Cancer Institute/MGH. Dr. Nadler is rated as a Distinguished provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Lung Cancer, Adenoid Cystic Carcinoma, Bone Tumor, and Pleuropulmonary Blastoma.
Texas Oncology, P.A.
Chandana Kakani is a Hematologist and an Oncologist in Flower Mound, Texas. Dr. Kakani is rated as an Advanced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. Her top areas of expertise are Alveolar Soft Part Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma, and Rhabdoid Tumor Predisposition Syndrome.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Hughes isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Hughes isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Hughes isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Hughes isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Hughes isDistinguished. Learn about Lung Cancer.
- Nasopharyngeal CarcinomaDr. Hughes isDistinguished. Learn about Nasopharyngeal Carcinoma.
- Advanced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Hughes isAdvanced. Learn about Adenoid Cystic Carcinoma.
- Anaplastic Thyroid CancerDr. Hughes isAdvanced. Learn about Anaplastic Thyroid Cancer.
- Bone TumorDr. Hughes isAdvanced. Learn about Bone Tumor.
- Epithelial-Myoepithelial Carcinoma
- Ewing SarcomaDr. Hughes isAdvanced. Learn about Ewing Sarcoma.
- Experienced
- Adrenal CancerDr. Hughes isExperienced. Learn about Adrenal Cancer.
- Adult Soft Tissue SarcomaDr. Hughes isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Hughes isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Hughes isExperienced. Learn about Alveolar Soft Part Sarcoma.
- AstrocytomaDr. Hughes isExperienced. Learn about Astrocytoma.
- Ataxia-Pancytopenia SyndromeDr. Hughes isExperienced. Learn about Ataxia-Pancytopenia Syndrome.